 low-molecular-weight heparin enoxaparin vs prevent postop deep vein thrombosi total hip replac danish enoxaparin studi group prospect studi thromboprophylact efficaci safeti low-molecular-weight heparin lmwh mg daili standard regimen dextran patient elect total hip replac deep vein thrombosi bilater phlebographi day oper forty-six patient elig analysi deep vein thrombosi patient lmwh group patient dextran group clinic symptom pulmonari embol patient studi postop period patient lmwh blood loss drain blood transfus patient dextran signific differ group respect total number blood transfus event advers event group none patient hospit studi patient lmwh group home day oper patient dextran develop symptomat deep vein thrombosi hospit discharg conclus enoxaparin effect thromboprophylact standard regimen dextran patient undergo total hip replac regimen safe clinic condit